Recent advances in prostate cancer metastasis

Area of Science:

• Oncology
• Urology
• Cancer Biology

Background:

• Prostate cancer is the most common non-cutaneous cancer in men, surpassing lung cancer.
• A significant discrepancy exists between the prevalence of latent prostate cancer and clinically apparent disease.
• Current methods cannot reliably predict which localized prostate cancers will become aggressive or metastasize.

Purpose of the Study:

• To review recent advances in identifying factors involved in prostate cancer metastasis.
• To highlight the need for molecular and cellular markers to predict invasive and metastatic potential.
• To improve therapeutic strategies by better understanding disease progression.

Main Methods:

• Literature review of recent studies on prostate cancer metastasis.
• Analysis of molecular and cellular features associated with the metastatic phenotype.
• Synthesis of current knowledge on factors driving prostate cancer progression.

Main Results:

• Latent prostate cancers are heterogeneous, with most not progressing to aggressive disease.
• Metastasis acquisition is a key criterion for substaging localized prostate cancers.
• Recent research is identifying features linked to the metastatic potential of prostate cancer.

Conclusions:

• Accurate prediction of prostate cancer progression and metastasis remains a significant clinical challenge.
• Identification of specific molecular and cellular markers is essential for personalized treatment strategies.
• Further research into the mechanisms of prostate cancer metastasis is critical for improving patient outcomes.